GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Liver Transplantation/Modified Cavo-Portal Hemi-Transposition in Adult LDLT: Annals of HPB Surgery | February 2026

Modified Cavo-Portal Hemi-Transposition in Adult LDLT: Annals of HPB Surgery | February 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated February 1, 2026

Quick Answer

Introduction Extensive porto-mesenteric thrombosis has traditionally been considered one of the most difficult situations in liver transplantation because adequate portal inflow is essential for graft regeneration and long-term function. In living donor liver transplantation, this challenge becomes even greater because the graft depends heavily on sufficient portal shear stress for recovery and growth.


Introduction

Extensive porto-mesenteric thrombosis has traditionally been considered one of the most difficult situations in liver transplantation because adequate portal inflow is essential for graft regeneration and long-term function. In living donor liver transplantation, this challenge becomes even greater because the graft depends heavily on sufficient portal shear stress for recovery and growth. Although alternative inflow options such as reno-portal anastomosis, cavo-portal hemi-transposition, portal vein arterialization, and multivisceral transplantation exist, each has important technical and physiological limitations. Among these, cavo-portal hemi-transposition is well described in pediatric transplantation but remains rarely reported in adults, especially in living donor liver transplantation.

Problem Statement

In adult living donor liver transplantation, cavo-portal hemi-transposition is technically difficult because the right lobe graft portal vein is not naturally aligned with the inferior vena cava. This can lead to angulation, poor flow, thrombosis, persistent portal hypertension, and inadequate systemic venous drainage, making outcomes less favorable in adults than in pediatric patients.

Summary

This article describes an important technical modification of cavo-portal hemi-transposition in two adult living donor liver transplant recipients with diffuse porto-mesenteric thrombosis, one of whom also had Budd-Chiari syndrome. The key modification was to use the left renal vein–inferior vena cava junction as the site for inflow and to add a cryopreserved portal vein graft as an interposition conduit. This created a straighter alignment between the graft portal vein and the systemic venous inflow, while avoiding excessive mobilization of the vena cava and preserving collateral venous channels. The authors believe this improves portal inflow, reduces the risk of kinking and thrombosis, and helps maintain adequate inferior vena cava drainage. One patient had good long-term graft function after management of partial portal vein thrombosis with stenting, while the second patient died from fungal sepsis despite a patent reconstruction. Overall, the study suggests that this modified technique is a practical rescue option in highly selected adult living donor liver transplantation cases with diffuse splanchnic venous thrombosis, but it should be performed only in expert high-volume transplant centers.

Related Q&A

Synbiotics After Liver Transplant Show No Clinical Benefit: Liver Transplant | July 2026

Introduction: Bacterial infections remain a major cause of morbidity after liver transplantation despite advances in perioperative care. Synbiotics, combining probiotics and prebiotics, have been proposed to reduce postoperative infections by restoring gut microbiota and strengthening...

Tranexamic Acid in Liver Transplantation: Liver Transplant | June 2026

Introduction: Perioperative bleeding remains a major challenge during orthotopic liver transplantation (OLT), largely due to hyperfibrinolysis and coagulation abnormalities. Although tranexamic acid (TXA) effectively reduces bleeding in several surgical settings, its routine prophylactic use during...

Whole-Organ Donor Liver Assessment Using PS-OCT: Science Translational Medicine | July 2026

Introduction: Liver transplantation is limited by a shortage of suitable donor organs. Current viability assessment relies on needle biopsy, which samples only a small portion of the liver and may miss important regional pathology. This...

Personalizing Antifibrinolytic Use in Liver Transplantation : Liver Transpl | Jul 2026

Introduction: Bleeding remains a major challenge during liver transplantation despite advances in surgical techniques, anesthesia, and perioperative care. Antifibrinolytic agents have long been used to reduce intraoperative blood loss and transfusion requirements. However, evolving transplant...

Integrating LDLT into Modern Liver Transplant Programs: Liver Transplantation | June 2026

Introduction: The demand for liver transplantation continues to exceed the availability of deceased donor organs, resulting in prolonged waiting times and preventable waitlist mortality. This perspective discusses how living donor liver transplantation (LDLT) can complement...

Post-Transplant Management in Pediatric LT: Liver Transplantation | June 2026

Introduction: Pediatric liver transplantation has achieved excellent survival rates, shifting the focus from graft survival alone to optimising long-term health, growth, neurodevelopment, and quality of life. This updated guideline provides evidence-based recommendations for comprehensive care...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer